Zhou YT, Yu LS, Zeng S, Huang YW, Xu HM, & Zhou Q. (2013). Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: Factors determining interaction strength and relevant clinical risk management. Dove Medical Press.
Čikaški stil citiranja (17. izdanje)Zhou YT, Yu LS, Zeng S, Huang YW, Xu HM, i Zhou Q. Pharmacokinetic Drug–drug Interactions Between 1,4-dihydropyridine Calcium Channel Blockers and Statins: Factors Determining Interaction Strength and Relevant Clinical Risk Management. Dove Medical Press, 2013.
MLA način citiranja (9. izdanje)Zhou YT, et al. Pharmacokinetic Drug–drug Interactions Between 1,4-dihydropyridine Calcium Channel Blockers and Statins: Factors Determining Interaction Strength and Relevant Clinical Risk Management. Dove Medical Press, 2013.